/connect-gujarat-english/media/post_banners/add4776093eb2490f6a1fd775dd093aba004d59ea8bd2c4c8fad1befbcdc9e0e.webp)
/connect-gujarat-english/media/post_banners/1e647b2aeadd1b1fd4dffd77df78795aa269654c5d5ce80b8937cb5a7f55829f.webp)
Today begins the COVID-19 vaccination for 15-18 age group
Only Bharat Biotech's 'Covaxin' would be provided in this population segment, according to the Union Health Ministry
/connect-gujarat-english/media/post_banners/950f2ef8cd7e53fa5c55a72d834e509105b00cab39746cc660152afdd7028431.webp)
Children Can Register For Vaccines From January 1, Use Student ID Card
Children in India will be vaccinated with one of two shots - either Bharat Biotech's double-dose Covaxin or Zydus Cadila's three-dose ZyCoV-D
/connect-gujarat-english/media/post_banners/43a67c3a567e6bd53c7ee9d1ba94e0083796ced2572c7a859391de21d31f1b89.webp)
New Zealand adds Covaxin, Covishield to list of recognised Covid-19 vaccines
After Australia, its New Zealand has recognied Covaxin and Covishield, the two most widely-used vaccines in India's vaccination drive
/connect-gujarat-english/media/post_banners/c9552966401ea4e171aae64dea5497839fd3aac3ec0cd61a33e62b312497119e.webp)
Australia gives nod to Bharat Biotech's Covaxin
Bharat Biotech’s Covaxin for establishing traveller’s vaccination status
/connect-gujarat-english/media/post_banners/d7736c16a477d86a9cce0a9471307fd2c6b7ee6b0f709bde66de71bd8eeca827.webp)
WHO needs 'additional clarifications' to approve Covaxin from Bharat Biotech
Bharat Biotech needs to present clarified details to WHO for Covaxin approval in emergency use
/connect-gujarat-english/media/post_banners/00fb93c83c5ea257ae2c22f42e406f86ba70f2da03560ff897c385e1645c2891.webp)
WHO to consider emergency listing of Covaxin on October 26
The World Health Organisation's technical advisory group will meet on October 26 to consider the EUL of Covaxin.
/connect-gujarat-english/media/post_banners/a6a53d2c6a45c85691dc64dedc303bf73c4768f58ecd987b7ae4d1fe9b7f8926.webp)
Bharat Biotech's Covaxin gets emergency approval for children aged 2-18 years
The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group
/connect-gujarat-english/media/post_banners/7ad992818fb33844f32ec7a0d47286ac0002c48b0b99c491eb817e787098b95b.webp)
/connect-gujarat-english/media/post_banners/6f0ed9f15a46a81cf496cc0b1777ea6516c58b4770fd9d5ba9d72ff94cbdee14.webp)
Web Stories